NCT02705716

Study Investigating Efficacy of an Occluding Dentifrice for Dentine Hypersensitivity

Short Term Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 409 (actual)
• Sponsor: GlaxoSmithKline · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

This study will investigate the efficacy of an experimental dentifrice containing 0.454% weight/weight (w/w) stannous fluoride in relieving dentine hypersensitivity (DH) after twice daily brushing, over a 2 week treatment period compared with a standard fluoride dentifrice.

Conditions

• Dentin Sensitivity

Interventions

Type	Name	Description
OTHER	0.454% w/w stannous fluoride (1100ppm fluoride)	Dentifrice containing 0.454% w/w stannous fluoride (1100ppm fluoride)
OTHER	0.76% sodium monofluorophosphate (1000ppm fluoride)	Dentifrice containing 0.76% sodium monofluorophosphate (1000ppm fluoride)

Timeline

• Start date: 2016-03-01
• Primary completion: 2016-05-20
• Completion: 2016-05-20
• First posted: 2016-03-10
• Last updated: 2017-04-25
• Results posted: 2017-04-25

Locations

3 sites across 1 country: United Kingdom